Assembly Biosciences, Inc.
NASDAQ:ASMB · NASDAQ Global Select
+$0.16 today
Vol 0.28M · Avg 0.17M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+42.92%
Period High
$38.50
Period Low
$17.08
Latest
$24.44
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Enanta Pharmaceuticals, Inc.
NASDAQ:ENTA
$290.21M
Nautilus Biotechnology, Inc.
NASDAQ:NAUT
$280.84M
Foghorn Therapeutics Inc.
NASDAQ:FHTX
$241.90M
Zura Bio Limited
NASDAQ:ZURA
$238.96M
Sagimet Biosciences Inc.
NASDAQ:SGMT
$217.48M
Arcturus Therapeutics Holdings Inc.
NASDAQ:ARCT
$211.59M
Immuneering Corporation
NASDAQ:IMRX
$156.46M
Pyxis Oncology, Inc.
NASDAQ:PYXS
$126.08M
Tenaya Therapeutics, Inc.
NASDAQ:TNYA
$116.42M
Aardvark Therapeutics, Inc. Common Stock
NASDAQ:AARD
$83.67M
What is the latest ASMB filing?
The latest filing shown is 4 dated Jun 5, 2026.
How many recent filings does ASMB have?
Intrinsic Alpha currently shows 20 recent filings for ASMB.
Explore More
Continue the stock analysis
Jump to another research area for this company.